Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)

Clinical trial NCT00684177 · COMPLETED

Trial details

NCT number: NCT00684177
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin Infections, Bacterial

Start date: 2008-05-01
Primary completion: 2009-10-01
Enrollment: 508

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.